Some of the world's most powerful pharmaceutical companies have backed down on planned price increases following a new transparency law in California and social media hectoring from President Donald Trump.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,